390.02 USD
▲-2.48+2.94%
盘后 388.17 +0.78%
2026-07-31
市值
$210.50B
市盈率
24.23
EPS
14.37
股息率
2.62%
52 周区间
269.77 – 398.00
成交量
3.62M
Beta
0.40
目标价
357.03
52W 低 269.7752W 高 398.00
价格走势
公司简介
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascul...